Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ananta Khurana

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Indian Dermatology Online Journal|October 13, 2022
Dermoscopy of Black HeelAnanta Khurana
Indian Journal of Dermatology, Venereology and Leprology|March 4, 2025
Time to change the established dogma on the diagnostic staging of hidradenitis suppurativaAnanta Khurana
Mycoses|May 1, 2012
An update on treatment of onychomycosisChander Grover, Ananta Khurana
Dermatologic Therapy|May 22, 2020
Immunosuppressive agents for dermatological indications in the ongoing COVID-19 pandemic: Rationalizing use and clinical applicabilityAnanta Khurana, Snigdha Saxena
Indian Journal of Dermatology, Venereology and Leprology|August 27, 2013
Telogen effluviumChander Grover, Ananta Khurana
Indian Journal of Dermatology, Venereology and Leprology|May 9, 2012
Onychomycosis: newer insights in pathogenesis and diagnosisChander Grover, Ananta Khurana
Indian Dermatology Online Journal|August 25, 2020
IADVL Position Statement and Recommendations on Post Lockdown Dermatology Practice Amidst the Covid -19 Pandemic (IADVL Academy and IADVL Executive Committee)Ananta Khurana, Deepika Pandhi
Journal of the American Academy of Dermatology|July 1, 2020
Using cyclosporine in the COVID era: An emergent need for cautionAnanta Khurana, Khushboo Sethia
The Indian Journal of Medical Research|March 6, 2020
Leprosy stigma & the relevance of emergent therapeutic optionsKabir Sardana, Ananta Khurana
Indian Journal of Dermatology, Venereology and Leprology|December 16, 2017
Reinterpreting minimum inhibitory concentration (MIC) data of itraconazole versus terbinafine for dermatophytosis - time to look beyond the MIC data?Ananta Khurana, Kabir Sardana
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Indian Dermatology Online Journal|October 13, 2022
Dermoscopy of Black HeelAnanta Khurana
Indian Journal of Dermatology, Venereology and Leprology|March 4, 2025
Time to change the established dogma on the diagnostic staging of hidradenitis suppurativaAnanta Khurana
Mycoses|May 1, 2012
An update on treatment of onychomycosisChander Grover, Ananta Khurana
Dermatologic Therapy|May 22, 2020
Immunosuppressive agents for dermatological indications in the ongoing COVID-19 pandemic: Rationalizing use and clinical applicabilityAnanta Khurana, Snigdha Saxena
Indian Journal of Dermatology, Venereology and Leprology|August 27, 2013
Telogen effluviumChander Grover, Ananta Khurana
Indian Journal of Dermatology, Venereology and Leprology|May 9, 2012
Onychomycosis: newer insights in pathogenesis and diagnosisChander Grover, Ananta Khurana
Indian Dermatology Online Journal|August 25, 2020
IADVL Position Statement and Recommendations on Post Lockdown Dermatology Practice Amidst the Covid -19 Pandemic (IADVL Academy and IADVL Executive Committee)Ananta Khurana, Deepika Pandhi
Journal of the American Academy of Dermatology|July 1, 2020
Using cyclosporine in the COVID era: An emergent need for cautionAnanta Khurana, Khushboo Sethia
The Indian Journal of Medical Research|March 6, 2020
Leprosy stigma & the relevance of emergent therapeutic optionsKabir Sardana, Ananta Khurana
Indian Journal of Dermatology, Venereology and Leprology|December 16, 2017
Reinterpreting minimum inhibitory concentration (MIC) data of itraconazole versus terbinafine for dermatophytosis - time to look beyond the MIC data?Ananta Khurana, Kabir Sardana
Pageof 13